Biotech stocks have been overlooked for the past year and a half, says Jefferies' Michael Yee

Michael Yee, Jefferies managing director, joins 'Power Lunch' to break down Moderna's quarterly earnings results, which companies in the biotech space are 'recession-proof' and near-term headline risk with the reconciliation bill making its way through Congress.